FDA Approves First Biosimilar to Treat Macular Degeneration

September 20th 2021

Biogen/Samsung Bioepis’ Byooviz is a biosimilar of Genentech’s Lucentis.

CMS Assigns J-Code for the Antibiotic Kimyrsa

September 20th 2021

Effective October 1, 2021, CMS will reimburse for the infusion product when dispensed in the outpatient setting.

FDA Approves Cabometryx for Thyroid Cancer

September 20th 2021

The approval comes more than two months ahead of its PDUFA target date of December 4, 2021.

Formulary Watch Drug Shortage Tracker — September 19, 2021

September 19th 2021

FDA Advisory Committee Supports COVID-19 Boosters for Some People

September 18th 2021

The vaccines advisory committee voted late on Friday, September 17, 2021, to provide emergency authorization of Pfizer’s COVID-19 vaccine as a booster for those over the age of 65, as well as for those at high risk of developing severe disease.